QA: MANNKIND CORP in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000899460_2023_MANNKIND_CORP.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.33904204729299103, 'aggregate_val': 163880000, 'exp_sum': 122386000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 16003000, 'SellingGeneralAndAdministrativeExpense': 37720000, 'ResearchAndDevelopmentExpense': 19721000, 'remainder_Expenses': 48942000}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000899460, MANNKIND CORP

  xvar xval
0 AssetsCurrent 234,896,000
1 IntangibleAssetsNetIncludingGoodwill 3,581,000
2 PropertyPlantAndEquipmentNet 45,126,000
3 remainder_Assets 11,679,000
4 LiabilitiesCurrent 67,296,000
5 LiabilitiesNoncurrent 43,027,000
6 remainder_Liabilities 435,497,000
7 CostOfGoodsAndServicesSold 16,003,000
8 SellingGeneralAndAdministrativeExpense 37,720,000
9 ResearchAndDevelopmentExpense 19,721,000
10 remainder_Expenses 90,436,000
11 remainder_Revenues 99,770,000
12 remainder_NetIncome -23,290,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 295,282,000
1 Liabilities 545,820,000
2 Expenses 163,880,000
3 Revenues 99,770,000
4 StockholdersEquity -250,538,000
5 NetIncome -87,400,000
6 ComprehensiveNetIncome -87,400,000
7 BaseVar 564,021,000
8 EconomicCapitalRatio -1.23

Edgar->Model Mapping

Feature Distribution

Change over Time